<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Anal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> originating from colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> is a rare occurrence that severely affects the patient's quality of life </plain></SENT>
<SENT sid="1" pm="."><plain>No standardized effective therapeutic strategy exists </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: Our aim was to examine clinicopathologic characteristics and outcome of patients with anal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of colorectal origin, directing particular attention to underlying mechanisms of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in relation to potential treatment strategies </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING AND PATIENTS: We identified patients with anal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of colorectal origin by reviewing medical records of patients treated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in a tertiary teaching hospital in the Osaka region of Japan between 2002 and 2009, and by searching the PubMed and Japanese Ichushi databases for patients reported in the literature </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: Clinical and pathologic variables were examined, including location, depth, and lymph node status of the primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e>; mode, timing, site, and symptoms of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>; as well as treatment and prognosis </plain></SENT>
<SENT sid="5" pm="."><plain>The mode of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was classified as either intraluminal or lymphovascular on the basis of clinical history of anal disease and/or histologic analysis of a resected specimen </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Of 851 patients with primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> treated at our institution, 6 patients (0.7%; 95% CI, 0.1-1.3%) had anal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, and 38 patients with anal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> of colorectal origin were identified in the literature; 43 patients could be analyzed </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesion</z:e> was located in the left colon in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="8" pm="."><plain>The metastatic mechanism was identified as intraluminal in 35 patients and lymphovascular in 8 patients </plain></SENT>
<SENT sid="9" pm="."><plain>Local recurrence after local resection was not reported in any patient with intraluminal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, but was found in 3 patients with lymphovascular <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, although <z:hpo ids='HP_0000001'>all</z:hpo> 3 had undergone wide resection </plain></SENT>
<SENT sid="10" pm="."><plain>LIMITATIONS: The study was observational in nature and included a small number of patients </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Treatment strategies for anal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> origin should consider the mechanism of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with suspected lymphovascular <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> should undergo radical resection beyond the primary and metastatic <z:e sem="disease" ids="C0003463" disease_type="Neoplastic Process" abbrv="">anal tumor</z:e> to eradicate remnant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, together with preoperative <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> therapy </plain></SENT>
</text></document>